Among patients who tested negative when screened for HCC by serum AFP level or abdominal ultrasound, the sensitivity (the percentage of patients who tested positive on the cfDNA test and had HCC detected on abdominal contrast-enhanced computed tomography) was 100% (4/4), while the specificity was 94% (307/324). The gene discussed is AFP; the disease is hepatocellular carcinoma.